171 related articles for article (PubMed ID: 32213095)
1. Predictors of Survival After Head and Neck Squamous Cell Carcinoma in South America: The InterCHANGE Study.
Abrahão R; Perdomo S; Pinto LFR; Nascimento de Carvalho F; Dias FL; de Podestá JRV; Ventorin von Zeidler S; Marinho de Abreu P; Vilensky M; Giglio RE; Oliveira JC; Mineiro MS; Kowalski LP; Ikeda MK; Cuello M; Munyo A; Rodríguez-Urrego PA; Hakim JA; Suarez-Zamora DA; Cayol F; Figari MF; Oliver J; Gaborieau V; Keogh RH; Brennan P; Curado MP;
JCO Glob Oncol; 2020 Mar; 6():486-499. PubMed ID: 32213095
[TBL] [Abstract][Full Text] [Related]
2. The ability of post-chemoradiotherapy DWI ADC
Connor S; Sit C; Anjari M; Lei M; Guerrero-Urbano T; Szyszko T; Cook G; Bassett P; Goh V
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2323-2336. PubMed ID: 34159420
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of human papillomavirus (HPV)-driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16
Sichero L; Tagliabue M; Mota G; Ferreira S; Nunes RAL; Castañeda CA; Castillo M; Correa RM; Perdomo S; Rodríguez-Urrego PA; Matos LL; Mohssen A; Gheit T; Tommasino M; Chiocca S; Villa LL;
Head Neck; 2022 Jan; 44(1):122-133. PubMed ID: 34726297
[TBL] [Abstract][Full Text] [Related]
4. HPV Positive Status Is a Favorable Prognostic Factor in Non-Nasopharyngeal Head and Neck Squamous Cell Carcinoma Patients: A Retrospective Study From the Surveillance, Epidemiology, and End Results Database.
Wu Q; Wang M; Liu Y; Wang X; Li Y; Hu X; Qiu Y; Liang W; Wei Y; Zhong Y
Front Oncol; 2021; 11():688615. PubMed ID: 34631523
[TBL] [Abstract][Full Text] [Related]
5. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus and Risk of Head and Neck Squamous Cell Carcinoma in Iran.
Karimi A; Mohebbi E; Mckay-Chopin S; Rashidian H; Hadji M; Peyghambari V; Marzban M; Naghibzadeh-Tahami A; Gholipour M; Kamangar F; Tommasino M; Gheit T; Zendehdel K
Microbiol Spectr; 2022 Aug; 10(4):e0011722. PubMed ID: 35708339
[TBL] [Abstract][Full Text] [Related]
7. Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol.
Farsi NJ; Rousseau MC; Schlecht N; Castonguay G; Allison P; Nguyen-Tan PF; Souliéres D; Coutlée F; Hier M; Madathil S; Franco EL; Nicolau B
Carcinogenesis; 2017 Dec; 38(12):1188-1195. PubMed ID: 29029021
[TBL] [Abstract][Full Text] [Related]
8. Outcomes Among Patients With Mucosal Head and Neck Squamous Cell Carcinoma Treated With Checkpoint Inhibitors.
Hobday SB; Brody RM; Kriegsman B; Basu D; Newman J; Cohen RB; Lukens JN; Singh A; D'Avella CA; Sun L
JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):918-926. PubMed ID: 35980666
[TBL] [Abstract][Full Text] [Related]
9. All HPV-negative head and neck cancers are not the same: Analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor microenvironment profiles.
Kim HAJ; Zeng PYF; Shaikh MH; Mundi N; Ghasemi F; Di Gravio E; Khan H; MacNeil D; Khan MI; Patel K; Mendez A; Yoo J; Fung K; Lang P; Palma DA; Mymryk JS; Barrett JW; Boutros PC; Nichols AC
Oral Oncol; 2021 May; 116():105260. PubMed ID: 33725617
[TBL] [Abstract][Full Text] [Related]
10. Detection of Human Papilloma Virus and Risk Factors among Patients with Head and Neck Squamous Cell Carcinoma Attending a Tertiary Referral Centre in South India.
Bandhary SK; Shetty V; Saldanha M; Gatti P; Devegowda D; R PS; Shetty AK
Asian Pac J Cancer Prev; 2018 May; 19(5):1325-1330. PubMed ID: 29802694
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
[TBL] [Abstract][Full Text] [Related]
12. The prevalence and clinicopathological correlation of human papillomavirus in head and neck squamous cell carcinoma in India: A systematic review article.
Nandi S; Mandal A; Chhebbi M
Cancer Treat Res Commun; 2021; 26():100301. PubMed ID: 33401132
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment.
Salazar CR; Smith RV; Garg MK; Haigentz M; Schiff BA; Kawachi N; Anayannis N; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
Head Neck Pathol; 2014 Mar; 8(1):77-87. PubMed ID: 24002971
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus and head and neck squamous cell carcinoma in a UK population: Is there an association?
Al-Dabbagh R; Al-Hazmi N; Alhazzazi TY; Barrett AW; Speight PM
Indian J Cancer; 2022; 59(1):65-72. PubMed ID: 33753602
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
[TBL] [Abstract][Full Text] [Related]
16. Long-term Survival in Head and Neck Cancer: Impact of Site, Stage, Smoking, and Human Papillomavirus Status.
Du E; Mazul AL; Farquhar D; Brennan P; Anantharaman D; Abedi-Ardekani B; Weissler MC; Hayes DN; Olshan AF; Zevallos JP
Laryngoscope; 2019 Nov; 129(11):2506-2513. PubMed ID: 30637762
[TBL] [Abstract][Full Text] [Related]
17. Small Cell and Squamous Cell Carcinomas of the Head and Neck: Comparing Incidence and Survival Trends Based on Surveillance, Epidemiology, and End Results (SEER) Data.
Bean MB; Liu Y; Jiang R; Steuer CE; Patel M; McDonald MW; Higgins KA; Beitler JJ; Shin DM; Saba NF
Oncologist; 2019 Dec; 24(12):1562-1569. PubMed ID: 31391295
[TBL] [Abstract][Full Text] [Related]
18. The impact of Human Papilloma Virus status on the prediction of head and neck cancer chemoradiotherapy outcomes using the pre-treatment apparent diffusion coefficient.
Connor S; Anjari M; Burd C; Guha A; Lei M; Guerrero-Urbano T; Pai I; Bassett P; Goh V
Br J Radiol; 2022 Feb; 95(1130):20210333. PubMed ID: 34111977
[TBL] [Abstract][Full Text] [Related]
19. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
[TBL] [Abstract][Full Text] [Related]
20. Head and Neck Cancer Stage at Presentation and Survival Outcomes Among Native Hawaiian and Other Pacific Islander Patients Compared With Asian and White Patients.
Moon PK; Ma Y; Megwalu UC
JAMA Otolaryngol Head Neck Surg; 2022 Jul; 148(7):636-645. PubMed ID: 35616952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
